Moreover, triciribine, which targets and reduces signaling in the ZNF275-induced AKT pathway, exhibited a tumor-suppressive role and sensitized cisplatin chemotherapy efficacy in cervical cancer expressing high ZNF275. This evidence concerns the gene ZNF275 and neoplasm.